RAPT Therapeutics, Inc.
Chemokine receptor modulators and uses thereof

Last updated:

Abstract:

Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of CCR4 activity.

Status:
Grant
Type:

Utility

Filling date:

19 Nov 2018

Issue date:

31 Mar 2020